manufacturing agreement

Recipharm, the contract development and manufacturing organisation (CDMO), and LIDDS have collaborated to set up a manufacturing line for LIDDS’ novel prostate cancer drug, Liproca Depot, at Recipharm’s development facility in Solna, Sweden. more

21 Jul 2017 11:24 News

Sun Pharma and Samsung BioLogics have entered into a long-term manufacturing agreement for an investigational IL-23p19 inhibitor, Tildrakizumab, for the treatment of moderate to severe plaque psoriasis. more

5 Jul 2017 12:15 News